Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 3Suspended 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 19Gastrointestinal 12Genitourinary 11Lymphoid 10Head & Neck 9CNS 9Thoracic 8Gynecologic 8Sarcoma 5Endocrine 5Plasma cell 4Other solid neoplasm 4Other hematologic neoplasm 4NET 4Tumor-Agnostic 3Dermatologic 3

Conditions

Solid Tumor 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Mesothelioma 1Hematopoietic and Lymphoid System Neoplasm 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 75Injections 67Carboplatin 38Pemetrexed 29Cisplatin 29Nivolumab 27Specimen Handling 24Interviews as Topic 24Cyclophosphamide 24atezolizumab 21tislelizumab 20Bevacizumab 20Paclitaxel 19Standard of Care 16Practice Guidelines as Topic 16fludarabine 15Docetaxel 15toripalimab 14Ipilimumab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Fluorodeoxyglucose F18 × Other solid neoplasm × 1 year × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT06383598 2026-04-07

PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors

Peking University Cancer Hospital & Institute

Phase NA Recruiting
50 enrolled
Other solid neoplasm

Solid Tumor

NCT05436093 2026-03-04

CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Peking University Cancer Hospital & Institute

Phase NA Recruiting
15 enrolled
Other solid neoplasm

Solid Tumor

NCT05844306 2025-11-19

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

City of Hope Medical Center

Phase NA Suspended
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡